Welcome to LookChem.com Sign In|Join Free
  • or
C18H16N2O4S is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1229661-75-9

Post Buying Request

1229661-75-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1229661-75-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1229661-75-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,9,6,6 and 1 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1229661-75:
(9*1)+(8*2)+(7*2)+(6*9)+(5*6)+(4*6)+(3*1)+(2*7)+(1*5)=169
169 % 10 = 9
So 1229661-75-9 is a valid CAS Registry Number.

1229661-75-9Relevant academic research and scientific papers

Design, synthesis and pharmacological screening of hybrid molecules as antihypertensives

Acharjee, Satarupa,Bothara, Kailash G.,Bhandari, Shashikant V.,Maity, Tapan K.

, p. 705 - 713 (2012/05/20)

The synthesis and pharmacological profile of a series of hybrid compounds bearing the dihydropyrimidine moiety and substituted phenylthioureas joined via typical b-blocker aryloxypropanolamine group are described. Seven out of 10 new compounds tested proved to be endowed with negative inotropic and chronotropic effect as compared to Adrenaline on isolated perfused frog heart. Also ECG studies that were carried out on normotensive male rats showed that the most of the compounds exhibited significant reduction in Rmax value in the first 30 min although maintaining little change in heart rate, with hypotensive effect lasting for 1 h.We concluded that the most of the synthesized novel compounds exhibited hypotensive as well as antihypertensive effects which could be attributed to blockade of Ca2+ entry and β-adrenoreceptor blocking activities due to introduction of aryloxypropanolamine linked to N-1 substituted dihydropyrimidine moiety. Brady cardiac effects of compounds 5a-5d, 6c-6e resulting from Ca2+entry and β-adrenoreceptor blocking attenuate the sympathetic activation-associated reflex tachycardia in the heart. We selected compound 5c as a promising lead for further detailed pharmacological and preclinical evaluation studies. Springer Science+Business Media, LLC 2010.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1229661-75-9